Hana Filková

Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy

Pavel Němec, Zuzana Zemanová, Henrieta Grešlíková et al. · Biology of Blood and Marrow Transplantation · 2009 · 70 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial

Pavel Němec, Zuzana Zemanová, Petr Kuglík et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 41 citations

Life Sciences, Genetics, Hematology +17

The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay

Markéta Wayhelová, Jan Smetana, Vladimíra Vallová et al. · BMC Medical Genomics · 2019 · 33 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma

Karel Zitterbart, Hana Filková, Lenka Tomášiková et al. · Journal of Neuro-Oncology · 2010 · 26 citations

Medicine, Genetics, Oncology +16

Case Report: Contiguous Xq22.3 Deletion Associated with ATS-ID Syndrome: From Genotype to Further Delineation of the Phenotype

Jan Smetana, Vladimíra Vallová, Markéta Wayhelová et al. · Frontiers in Genetics · 2021 · 20 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17